PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions

AbCellera Biologics Inc. (ABCL)

Equity · Currency in USD · Last updated Feb 24, 2024
SummaryFinancials

Company Info

ISINCA00288U1066
CUSIP00288U106
SectorHealthcare
IndustryBiotechnology

Highlights

Market Cap$1.43B
EPS-$0.51
Revenue (TTM)$38.03M
Gross Profit (TTM)$311.11M
EBITDA (TTM)-$212.81M
Year Range$3.87 - $8.63
Target Price$15.38
Short %11.75%
Short Ratio18.05

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM2023202220212020
Revenue

Total Revenue

38.03M38.03M485.42M11.61M233.16M

Cost Of Revenue

0.000.0066.44M45.52M27.14M

Gross Profit

38.03M38.03M418.99M11.61M206.01M
Operating Expenses

Selling, General & Admin Expenses

64.10M75.18M55.49M2.75M11.91M

R&D Expenses

175.66M175.66M107.88M62.06M29.39M

Total Operating Expenses

261.08M261.08M191.92M13.95M41.66M
Income

Income Before Tax

-174.03M-174.03M239.10M-2.21M157.83M

Operating Income

-230.46M-223.05M216.51M-4.12M156.03M

EBIT

-160.38M0.00216.51M-2.00M156.03M

Earnings From Continuing Operations

-146.40M-146.40M158.52M153.46M118.92M

Net Income

-146.40M-146.40M158.52M-2.21M118.92M

Income Tax Expense

-26.18M0.0080.58M65.69M38.92M

Interest Expense

16.73M0.004.05M209.20K6.51M

Other Non-Operating Income (Expenses)

16.53M6.78M22.59M1.91M1.80M

Extraordinary Items

0.000.000.000.000.00

Discontinued Operations

0.000.000.000.000.00

Effect Of Accounting Charges

0.000.000.000.000.00

Non Recurring

0.000.0066.44M45.52M0.00

Minority Interest

0.000.000.000.000.00

Other Items

0.000.000.000.000.00
Values in USD except per share items